MK-7962

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7962, covering 2025-02-25 to 2025-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021) [Phase 1]